BAY COLONY ADVISORY GROUP, INC D/B/A BAY COLONY ADVISORS – CRISPR Therapeutics AG Transaction History
BAY COLONY ADVISORY GROUP, INC D/B/A BAY COLONY ADVISORS portfolio value:
$482,000
portfolio value
BAY COLONY ADVISORY GROUP, INC D/B/A BAY COLONY ADVISORS quarter portfolio value change:
+7.54%
quarter
CRISPR Therapeutics AG 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -71K | $65.35 | 7.37K | |
| Q2 2022 | share | Increase | +27.73% | 1.6K shares | 191K | $60.77 | 7.37K |
| Q1 2022 | share | Increase | +9.45% | 498 shares | -38K | $62.77 | 5.77K |
| Q4 2021 | share | Increase | +32.76% | 1.30K shares | -44K | $78.85 | 5.27K |
| Q3 2021 | share | Decrease | -0.70% | -28 shares | -203K | $111.93 | 3.97K |
| Q2 2021 | share | 0.00% | 0 shares | 160K | $161.89 | 3.99K | |
| Q1 2021 | share | Increase | +55.60% | 1.42K shares | 94K | $121.85 | 3.99K |
| Q4 2020 | share | Decrease | -32.28% | -1.22K shares | 76K | $153.11 | 2.57K |
| Q3 2020 | share | Increase | +24.43% | 745 shares | 93K | $83.64 | 3.79K |
| Q2 2020 | share | Increase | 0.00% | 3.05K shares | 224K | $73.49 | 3.05K |
| Q1 2020 | share | Decrease | -100.00% | -3.95K shares | -231K | $42.41 | 0 |
| Q4 2019 | share | Decrease | -20.20% | -1K shares | 28K | $60.91 | 3.95K |
| Q3 2019 | share | 0.00% | 0 shares | -30K | $40.99 | 4.95K | |
| Q2 2019 | share | Decrease | -16.10% | -950 shares | 27K | $47.1 | 4.95K |
| Q1 2019 | share | Increase | 0.00% | 5.9K shares | 206K | $35.72 | 5.9K |